NCR3 and neuroblastoma: In high-risk neuroblastoma, the NKp30 ligand B7-H6, present on neuroblastoma cells, binds NKp30 and determines NK cell stimulation; however, the soluble form of B7-H6 has the opposite result, increasing metastases and resistance to chemotherapy [65].